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We present a case report to show how manganese-enhanced
T1- and T2-weighted MR cholangiography could differentiate
cystic parenchymal lesions from cystic abnormalities which
communicate with the bile ducts.
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INTRODUCTION
Recently, several studies reported the useful-
ness of manganese-enhanced T1-weighted MR
cholangiography in evaluating the biliary system,
reflecting the dynamics of bile flow.1-6 We illus-
trate here a case report to show how manganese-
enhanced T1- and T2-weighted MR cholangio-
graphy could differentiate cystic parenchymal
lesions from cystic abnormalities which communi-
cate with the bile ducts.
CASE REPORT
A 53-year-old-man was referred to our hospital
because of abnormal findings on CT scan for
health screening showing multiple, nonenhancing,
small, hypodense nodules scattered throughout
his entire liver. He did not have any malignant
disease. Laboratory findings including liver
function and blood chemistry were normal. To
differentiate from multiple cysts, ultrasonography
was performed. Hepatic US shows an inhomo-
geneous echo texture with some hypoechoic and
hyperechoic nodules. We could not differentiate
cystic lesions from solid nodules on CT and
sonography. Bile duct was not dilated. MR
cholangiography was performed with a 1.5-T
superconducting unit (Magnetom Vision; Siemens
Medical Systems, Erlangen, Germany) and a
phased-array torso coil. The precontrast T2-
weighted MR cholangiography using a half-Fou-
rier rapid acquisition with relaxation enhancement
(RARE) sequence with breath holds (TR/effective
TE, infinite/95 msec; matrix, 240 × 256; field of
view, 300 - 350 mm) showed multiple, small, and
well-defined high signal intensity foci scattered
throughout the liver, suggesting as multiple cystic
lesions. And bile ducts appeared as high signal
intensity structures. The relationship between the
bile ducts and the multiple small cystic lesions
could not be clarified in this study. Post-man-
ganese 3D T1-weighted fat-saturated volumetric
interpolated breath-hold images (TR/TE, 4.2/1.6;
flip angle, 120; matrix 205 × 256; field of view,
300- 350 mm; and 24 partitions interpolated to 48
slices with a thickness of 1.3 mm) showed only
bile ducts as high signal intensity structures. Post-
manganese enhanced T2-weighted MR cholangio-
graphy showed persistent high signals in the
multiple small cystic lesions and the loss of bile
duct signals. Manganese-enhanced T1- and T2-
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weighted MR cholangiography clearly showed
that there was no communication between the bile
ducts and cystic lesions.
DISCUSSION
Recently, several studies reported the usefulness
of manganese-enhanced T1-weighted MR cholan-
giography in evaluating the biliary system.1-6
Because manganese is a paramagnetic metal ion,
it acts primarily on T1, resulting in T1 shortening,
while also acting on and shortening T2.1-6
Enhanced liver and functioning bile ducts, there-
fore, have higher signal intensity on T1- weighted
images and lower signal intensity on T2-weighted
images.1-6 Therefore, mangafodipir trisodium is
primarily used as a positive contrast agent of
T1-weighted MR cholangiography. Additionally,
it acts as a negative contrast agent on conven-
tional heavily T2-weighted MR cholangiography.
On T2-weighted MR cholangiography after
manganese administration, signal intensity is lost
in the functioning bile duct, but persists in the
non-functioning bile duct or the non-communi-
cating structure with the bile ducts. This charac-
teristic property of combined T1- and T2-weighted
MR cholangiography before and after admini-
stration of mangafodipir trisodium could be used
as an excellent imaging tool in evaluating biliary
dynamics.
1-6
After mangafodipir trisodium injection, in our
study, T1-weighted MR cholangiography only
depicted the draining bile ducts as high signal
intensity structures whereas T2-weighted MR
cholangiography depicted the cystic lesions as
well as the bile ducts as high signal intensity foci.
They allowed us to separate the draining bile
ducts from the cystic lesions, providing clear
evidence of no communication between them.
Therefore, manganese-enhanced T1- and T2-
weighted MR cholangiography allow the differen-
tiation of cystic parenchymal lesions from dilated
biliary ducts or other bile duct anomalies com-
Fig. 1. A 53-year-old-man with multiple biliary hamartomas. (A) Contrast-enhanced CT shows multiple, nonenhancing,
small, hypodense nodules scattered throughout his entire liver. (B) Hepatic US shows an inhomogeneous echo texture with
some hypoechoic (white arrow) and hyperechoic (black arrow) nodules. We could not differentiate cystic lesions from solid
nodules on CT and sonographic findings. (C) Coronal pre-mangafodipir half-Fourier RARE MR cholangiographic image
shows multiple, small, and well-defined high signal intensity lesions scattered throughout the liver. The bile ducts appeared
as high signal intensity structures (arrow). The relationship between the bile ducts and the multiple small high signal
intensity lesions could not be clarified in this study. (D) Coronal MIP from post-mangafodipir 3D fat-suppressed T1-
weighted gradient echo image shows only bile ducts (arrow) as high signal intensity structures. (E) As in (A), following
mangafodipir administration. There is loss of bile duct signals, but signal persists in the multiple small cystic lesions.
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municating with the normal bile ducts. Mortele, et
al.7 reported that MR cholangiography allowed
differentiation of biliary hamartomas from dilated
bilary ducts or other bile duct anomalies, such as
Caroli's disease. They suggested that conventional
T2-weighted MR cholangiography provided
information on the communication between the
hamartomas and the draining bile ducts.7 They
also reported that the draining bile ducts in their
subjects appeared normal.7 However, we disagree
with their opinion, because conventional T2-
weighted MR cholangiography cannot separate
the draining bile ducts from cystic parenchymal
lesions.
In conclusion, pre- and post-manganese-en-
hanced T1- and T2-weighted MR cholangiography
makes it possible to differentiate cystic
parenchymal lesions from cystic abnormalities
which communicate with the bile ducts.
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